TSX:APTXPharmaceuticals
Why Apotex Health (TSX:APTX) Is Up 7.1% After First Generic Semaglutide Approval In Canada
Apotex Health Corp. recently became the first company to secure Health Canada approval for SEVMIA, a generic semaglutide injection for chronic weight management in adults with obesity or overweight and related cardiovascular risk.
This move expands Apotex’s presence in obesity and cardiovascular care while potentially broadening access to lower-cost GLP-1 therapy across Canada.
We’ll now examine how being first to offer a generic semaglutide option for obesity care shapes Apotex Health’s...